Market Research Future has announced the addition of the ‘Recombinant DNA Technology Market: Global Industry Analysis 2017-2018 and Opportunity Assessment 2018–2023″ report to their offering. Report presents a revised forecast of the global Recombinant DNA Technology Market for a 5-year period 2018-2023 with respect to four main geographies and their countries- Americas, Europe, Asia Pacific and Middle East and Africa.
Market Highlights:
The recombinant DNA technology is a process that manipulates and alters the DNA sequences, resulting in a genetically modified organism and product. These genetically modified products or organisms have superior or specific ability such as resistance to certain chemicals, high productivity, and survival abilities in harsh conditions (GM crops).
The recombinant DNA technology has a practical application of biotechnology in the fields of applied immunology, genomics, diagnostic tools, and development of pharmaceutical therapeutics. There are numerous biological methods used to create a recombinant DNA. The treatment was developed for leukemia disorder, in conjugation between the Novartis Corp and the University of Pennsylvania.
Factors such as the commercial success of the recombinant DNA technology in the biopharmaceutical industry, the increasing adoption of genetically modified crops and biopesticides, and the increasing burden of chronic diseases are driving the growth of the market. Moreover, the increasing need to improve the recombinant protein production capacity and the presence of robust biopharmaceuticals pipeline are increasing the demand for effective therapeutics for disease treatment.
Presently, the genetic testing market is majorly spread in Western Europe and North American. There are vast opportunities for the companies and service providers to make the tests affordable and enter the untapped regions of the world with a great scope of expanding.
The global recombinant DNA technology market is expected to grow at a CAGR of approximately 6.9% during the forecast period, 2017–2023.
Get Exclusive Sample Report Here – https://www.marketresearchfuture.com/sample_request/5845
Recombinant DNA Technology Market – Leading players
- Hoffmann-La Roche Ltd (Switzerland)
- Profacgen (U.S.)
- Amgen Inc. (U.S.)
- Novartis AG (Switzerland)
- Genscript Biotech (U.S.)
- Pfizer Inc. (U.S.)
- Novo Nordisk A/S (Denmark)
- Eli Lilly and Company (U.S.)
- Sanofi S.A. (France)
- Merck & Co., Inc. (U.S.)
- Biogen Inc. (U.S.)
- Biocon Limited (India)
- GlaxoSmithKline plc (UK)
- New England Biolabs (U.S.)
- Cibus (U.S.)
- Monsanto Company (U.S.)
- Horizon Discovery Group PLC (U.S.)
- Boehringer Ingelheim (Germany), and others.
Global Recombinant DNA Technology Market – Regional Analysis
The global recombinant DNA technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas region holds the largest market share of the global recombinant DNA technology market due to the presence of effective regulations pertaining to the approval of recombinant therapeutics and other Genetically Modified (GM) products. F. Hoffmann-La Roche Ltd, Amgen Inc., Novartis AG, Monsanto Company, Eli Lilly and Company, and Biogen Inc. are some of the major companies operating in this space that are responsible for the growth of the Americas recombinant DNA technology market.
Furthermore, there is an increasing need to improve the recombinant proteins production capacity by several folds in Europe. The increase in demand for effective therapeutics for the treatment of diseases and technological advancements in this sector are anticipated to drive the growth of the European recombinant DNA technology market.
Asia Pacific is expected to emerge as the fastest growing regional market for the global recombinant DNA technology market. The increasing awareness about the growing genetic diseases and disorders, developing healthcare infrastructure, increasing spending on healthcare, increasing government initiatives to improve public health, and advances in medical fields are driving the market growth.
The Middle East and Africa is expected to experience a limited growth due to less demand for genetic testing. The Middle East is growing significantly as compared to the African recombinant DNA technology market owing to the increase in aging population, innovations in genetic testing, and increase in the number of chronic disease cases.
Global Recombinant DNA Technology – Market Segmentation
The global recombinant DNA technology market is segmented on the basis of product, component, application, and end-user.
On the basis of product, the global recombinant DNA technology market is segmented into medical, non-medical, and others. The medical segment is divided into therapeutic agent, human protein, and vaccines. The non-medical segment is divided into biotech crops, specialty chemicals, and others.
On the basis of component, the global recombinant DNA technology market is segmented into expression system, cloning vector, and others. The expression system segment is divided into mammalian, bacteria, yeast, baculovirus/insect, and others. The cloning vector segment is divided into plasmid, phage, cosmid, Bacterial Artificial Chromosome (BAC), Yeast Artificial Chromosome (YAC), and Human Artificial Chromosome (HAC).
On the basis of application, the global recombinant DNA technology market is segmented into food and agriculture, health and disease, environment, and others.
On the basis of end-user, the global recombinant DNA technology market is segmented into biotechnology companies, academic and government research institutes, pharmaceuticals, and others.
Get Discount on Customize Report – https://www.marketresearchfuture.com/check-discount/5845
TOC of Recombinant DNA Technology Market Research Report – Global Forecast to 2023
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Recombinant DNA Technology Market, By Product
6 Global Recombinant DNA Technology Market, By Component
7 Global Recombinant DNA Technology Market, By Application
8 Global Recombinant DNA Technology Market, By End-U.S.Er
9 Global Recombinant DNA Technology Market, By Region
10 Competitive Landscape
11 Company Profile
12 MRFR Conclusion
LIST OF TABLES
Table 1 Recombinant DNA Technology Industry Synopsis, 2017–2023
Table 2 Recombinant DNA Technology Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Recombinant DNA Technology Market, By Region, 2017–2023, (USD Million)
Table 4 Recombinant DNA Technology Market, By Product, 2017–2023, (USD Million)
Table 5 Recombinant DNA Technology Market, By Component, 2017–2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation Of The Recombinant DNA Technology Market
Figure 3 Segmentation Market Dynamics For The Recombinant DNA Technology Market
Figure 4 Global Recombinant DNA Technology Market Share, By Product 2016
Figure 5 Global Recombinant DNA Technology Market Share, By Component 2016
TOC CONTINUED…
Ask to Our Experts https://www.marketresearchfuture.com/enquiry/5845
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
